MicroSigX Announces Promising Early Results from a Groundbreaking Multicenter Study on M3CRC Colorectal Cancer Screening at DDW 2025
We are thrilled to announce the promising early results from our groundbreaking multicenter study on colorectal cancer screening, which will be presented at Digestive Disease Week (DDW) 2025, from May 3-6, in San Diego, USA.
Conducted across nine centers in the Asia-Pacific region, this study on a stool-based panel of bacterial gene markers (M3CRC) represents a significant advancement in colorectal cancer diagnostics. “Our extensive collaboration ensures comprehensive and diverse data, making our findings more reliable and applicable across different populations,” said Rachel Fan, CEO of MicroSigX.
CUHK research investigator Dr. Louis Ho Shing Lau will present the early results of M3CRC from the Hong Kong, Japan, and Singapore cohorts at Digestive Disease Week (DDW) 2025, a prestigious conference in gastroenterology. DDW attracts top researchers and clinicians from around the world, offering unparalleled visibility and recognition for innovative research.
Stay tuned for more updates!
Event: Digestive Disease Week 2025
Category: Clinical Practice (CP)
Subcategory Description: Colorectal Cancer Screening and Surveillance: Innovations, New Technology
Presenter: Louis Ho Shing Lau, CUHK Medicine
#DDW2025
#MicroSigX
#M3CRC
#ColorectalCancer
#Screening
#CancerResearch
GenieBiome Limited 精進微生物科技有限公司
Microbiota I-Center (MagIC) (香港微生物菌群創新中心)
CUHK Medicine
